A study on the binding-selectivity for DAMGO, a selective mu-opioid receptor agonist, using opioid mu/kappa- chimeric receptors
Katao, Y.; Minami, M.; Onogi, T.; Katsumata, S.; Toya, T.; Nakagawa, T.; Aoki, Y.; Satoh, M.
Japanese Journal of Pharmacology 67(Suppl 1): 172P
1995
ISSN/ISBN: 0021-5198
Accession: 029808770
PDF emailed within 1 workday: $29.90
Related References
Minami, M.; Satoh, M. 1995: A study on the structural basis of opioid receptors for the subtype-selective binding of DAMGO, a mu-opioid receptor selective agonist, using chimeric opioid receptors Folia Pharmacologica Japonica 106(Suppl 1): 162P-166PMinami, M.; Onogi, T.; Nakagawa, T.; Katao, Y.; Aoki, Y.; Katsumata, S.; Satoh, M. 1995: DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors Febs Letters 364(1): 23-27
Onogi, T.; Minami, M.; Katao, Y.; Nakagawa, T.; Aoki, Y.; Toya, T.; Katsumata, S.; Satoh, M. 1995: DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops Febs Letters 357(1): 93-97
Villar, V.M.; Rahmani, N.H.; Bhargava, H.N. 1995: Effect of chronic administration of naltrexone on brain mu- and kappa-opioid receptors and responses to U-50,488H, a kappa-opioid receptor agonist in the mouse FASEB Journal 9(3): A102
Dehaven, R.N.; Cassel, J.A.; Daubert, J.D.; Gauntner, E.K.; Mansson, E. 1999: A chimeric mu/kappa opioid receptor that functions as a mu opioid receptor with selectivity for dynorphin A Society for Neuroscience Abstracts 25(1-2): 180
Ni, Q.; Xu, H.; Partilla, J.S.; de Costa, B.R.; Rice, K.C.; Rothman, R.B. 1993: Selective labeling of kappa 2 opioid receptors in rat brain by [125I]IOXY: interaction of opioid peptides and other drugs with multiple kappa 2a binding sites Peptides 14(6): 1279-1293
da Fonseca Pacheco, D.; Klein, A.; de Castro Perez, A.; da Fonseca Pacheco, C.M.; de Francischi, J.N.; Duarte, I.D.G. 2008: The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors British Journal of Pharmacology 154(5): 1143-1149
Watson, B.; Meng, F.; Akil, H. 1996: A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands Neurobiology of Disease 3(1): 87-96
Kim, K.W.; Soh, S.M.; Kim, H.I.; Rho, H.W.; Cho, K.P. 1994: Characteristics of diprenophrine binding to kappa opioid receptors in human cortex Kappa opioid receptor heterogeneity Regulatory Peptides 54(1): 149-150
Park, Y.; Ma, T.; Jang, C.G.; Tanaka, S.; Ko, K.H.; Loh, H.H.; Ho, I.K. 1999: Mu-, delta- and kappa-opioid agonist stimulated GTPgammaS binding in the mu-opioid receptor gene knockout mice Society for Neuroscience Abstracts 25(1-2): 179
Clarke, S.; Zimmer, A.; Zimmer, A.M.; Hill, R.G.; Kitchen, I. 2003: Region selective up-regulation of mu-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice Neuroscience 122(2): 479-489, 3 December
Clarke, S.; Zimmer, A.; Zimmer, A.M.; Hill, R.G.; Kitchen, I. 2003: Region selective up-regulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice Neuroscience 122(2): 479-489
Xin, J.; Zhang, Y.; He, Z.; Wang, Z. 2016: Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin a protects against forebrain ischemia-induced brain injury in rats Brain Research 1637: 168-176
Zhao, G.-M.; Qian, X.; Schiller, P.W.; Szeto, H.H. 2003: Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors Journal of Pharmacology and Experimental Therapeutics 307(3): 947-954
Mizutani, M.; Ukai, M.; Kameyama, T. 1994: Effects of dopamine antagonist and kappa-selective opioid agonist on the delta-selective opioid agonist enkephalin-induced behavioral alterations in mice Japanese Journal of Pharmacology 64(Suppl 1): 179P